Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.590
-0.005 (-0.91%)
At close: Jan 14, 2025, 4:00 PM
0.620
+0.030 (5.10%)
After-hours: Jan 14, 2025, 7:54 PM EST
Adaptimmune Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ADAP stock have an average target of 2.79, with a low estimate of 1.50 and a high estimate of 3.50. The average target predicts an increase of 372.96% from the current stock price of 0.59.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 27, 2024.
Analyst Ratings
The average analyst rating for ADAP stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $3 → $1.5 | Buy | Maintains | $3 → $1.5 | +154.28% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +493.32% | Nov 19, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +408.56% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $3.5 | Strong Buy | Maintains | $4 → $3.5 | +493.32% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +578.08% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
183.80M
from 60.28M
Increased by 204.91%
Revenue Next Year
40.12M
from 183.80M
Decreased by -78.17%
EPS This Year
-0.16
from -0.57
EPS Next Year
-0.44
from -0.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 202.0M | 58.8M | 80.8M | |||
| Avg | 183.8M | 40.1M | 62.9M | |||
| Low | 171.3M | 15.5M | 43.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 235.1% | -68.0% | 101.3% | |||
| Avg | 204.9% | -78.2% | 56.9% | |||
| Low | 184.2% | -91.5% | 8.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.04 | -0.11 | -0.05 |
| Avg | -0.16 | -0.44 | -0.35 |
| Low | -0.20 | -0.58 | -0.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.